News Home

Will Sorrento Therapeutics Inc (SRNE) Stay at the Bottom of the Healthcare Sector?

Thursday, December 08, 2022 04:02 PM | InvestorsObserver Analysts

Mentioned in this article

Will Sorrento Therapeutics Inc (SRNE) Stay at the Bottom of the Healthcare Sector?

Sorrento Therapeutics Inc (SRNE) is around the bottom of the Healthcare sector according to InvestorsObserver. SRNE received an overall rating of 20, which means that it scores higher than 20% of stocks. Additionally, Sorrento Therapeutics Inc scored a 28 in the Healthcare sector, ranking it higher than 28% of stocks in that sector.

Overall Score - 20
SRNE has an Overall Score of 20. Find out what this means to you and get the rest of the rankings on SRNE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 20 would rank higher than 20 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Sorrento Therapeutics Inc Stock Today?

Sorrento Therapeutics Inc (SRNE) stock is flat 0% while the S&P 500 is up 0.63% as of 4:00 PM on Thursday, Dec 8. SRNE is flat $0.00 from the previous closing price of $1.08 on volume of 4,000,186 shares. Over the past year the S&P 500 is down -15.79% while SRNE has fallen -82.83%. SRNE lost -$1.33 per share the over the last 12 months. Click Here to get the full Stock Report for Sorrento Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App